Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1991 Feb;82(2):146–156. doi: 10.1111/j.1349-7006.1991.tb01822.x

Cytochrome P‐450 Isozyme Pattern Is Related to Individual Susceptibility to Diethylnitrosamine‐induced Liver Cancer in Rats

Antero Aitio 1,✉, Mirja‐Liisa Aitio 1, Anne‐Marie Camus 1, Elisabeth Cardis 1, Helmut Bartsch 1
PMCID: PMC5918375  PMID: 1848544

Abstract

Differences in susceptibility to chemical carcinogenesis between rodent strains and species have been linked to variations in genetically‐determined mixed function oxidase activities. In order to verify whether such variations also determine the susceptibility of individual animals of the same strain to a chemical carcinogen, outbred male Wistar rats were administered diethylnitrosamine (DEN) (1, 2, or 3 nig/kg) five times a week for 20 weeks. The relationship was examined between the outcome (i.e. presence or absence of liver tumors, and latency period) and the hepatic activities of mixed function oxidases and conjugating enzymes, as well as of O6‐methylguanine‐DNA‐methyltransferase, measured before the carcinogen treatment. In addition, the metabolic profiles of two model drugs, antipyrine and disopyramide, in the urine were analyzed and correlated with the carcinogen susceptibility. The length of the latency period of hepatocellular tumors in individual rats was negatively related to the activities of hepatic dimethylnitrosamine N‐demethylase, aryl hydrocarbon hydroxylase and epoxide hydrolase and positively related to the amount of microsomal protein. Consistent relationships between the other 10 measured parameters and the susceptibility to DEN‐induced carcinogenesis were not detected. Long‐term treatment with DEN slightly decreased the proportion of metabolism of antipyrine into norantipyrine, and increased the share of 4‐hydroxyantipyrine; a decrease in the metabolism of disopyramide to N‐deisopropyldisopyramide was also detected. It is concluded that the pattern of cytochrome P‐450 isoenzymes is related to differences in individual susceptibility to nitrosamineinduced carcinogenesis. The relationship was most marked at low dose levels, which are the levels at which nitrosamine exposures of humans are known to occur.

Keywords: Nitrosamine, Hepatocellular tumor, Cytochrome P‐450, Monooxygenase, Individual susceptibility

Full Text

The Full Text of this article is available as a PDF (719.9 KB).

REFERENCES

  • 1. ) Tatematsu , M. , Nakanishi , K. , Murasaki , G. , Miyata , Y. , Hirose , M. and Ito , N.Enhancing effect of inducers of liver microsomal enzymes on induction of hyperplastic liver nodules by N‐2‐fluorenylacetamide in rats . J. Natl. Cancer Inst. , 63 , 1411 – 1416 ( 1979. ). [PubMed] [Google Scholar]
  • 2. ) Wattenberg , L. W. and Leong , J. L.Inhibition of the carcinogenic action of 7,12‐dimethylbenzanthracene by beta‐naphthoflavone (33161) . Proc. Soc. Exp. Biol Med. , 128 , 940 – 943 ( 1968. ). [Google Scholar]
  • 3. ) Slaga , T. J. , Thompson , S. , Berry , D. L. , DiGiovanni , J. , Juchau , M. R. and Viaje , A.The effects of benzoflavones on polycyclic hydrocarbon metabolism and skin tumor initiation . Chem.-Biol. Interact. , 17 , 297 – 312 ( 1977. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) DiGiovanni , J. , Berry , D. L. , Juchau , M. R. and Slaga , T.2,3,7,8‐Tetrachlorodibenzo‐p‐dioxin: potent anticarcinogenic action in CD‐1 mice . Biochem. Biophys. Res. Commun. , 86 , 577 – 584 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) DiGiovanni , J. , Berry , D. L. , Gieason , G. L. , Kishore , G. S. and Slaga , T. J.Time‐dependent inhibition by 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin of skin tumorigenesis with polycyclichydrocarbons . Cancer Res. , 40 , 1580 – 1587 ( 1980. ). [PubMed] [Google Scholar]
  • 6. ) Kouri , R. E. , Billups , L. H. , Rude , T. H. , Whitmire , C. E. , Sass , B. and Henry , C. J.Correlation of inducibility of aryl hydrocarbon hydroxylase with susceptibility to 3‐methylcholanthrene‐induced lung cancers . Cancer Lett. , 9 , 277 – 284 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Pelkonen , O. , Boobis , A. R. , Levitt , R. C. , Kouri , R. E. and Nebert , D. W.Genetic differences in the metabolic activation of benzo[a]pyrene in mice. Attempts to correlate tumorigenesis with binding of reactive intermediates to DNA and with mutagenesis in vitro . Pharmacology , 18 , 281 – 293 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Diwan , B. A. and Blackman , K. E.Carcinogenic effects of combined treatment of inbred mice with 3‐methylcholan‐threne and 1,2‐dimethylhydrazine . J. Natl Cancer Inst. , 64 , 1491 – 1493 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Asamoto , M. , Tsuda , H. , Kato , T. , Ito , N. , Masuko , T. , Hashimoto , Y. and Nagase , S.Strain differences in susceptibility to 2‐acetylaminofluorene and phenobarbital promotion of hepatocarcinogenesis: immunohistochemical analysis of cytochrome P‐450 isozyme induction by 2‐acetylaminofluorene and phenobarbital . Jpn. J. Cancer Res. , 80 , 1041 – 1046 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Kellermann , G. , Shaw , C. R. and Luyten‐Kellermann , M.Aryl hydrocarbon hydroxylase inducibility and bronchogenie carcinoma . New Engl. J. Med. , 289 , 934 – 937 ( 1973. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) McLemore , T. L. , Martin , R. R. , Wray , N. P. , Cantrell , E. T. and Busbee , D. L.Reassessment of the relationship between aryl hydrocarbon hydroxylase and lung cancer . Cancer , 48 , 1438 – 1443 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Idle , J. R. , Mahgoub , A. , Sloan , T. P. , Smith , R. L. , Mbanefo , C. O. and Bababumni , E. A.Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer . Cancer Lett. , 11 , 331 – 338 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Caporaso , N. , Hayes , R. B. , Dosemeci , M. , Hoover , R. , Ayesh , R. , Hetzel , M. and Idle , J.Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype . Cancer Res. , 49 , 3675 – 3679 ( 1989. ). [PubMed] [Google Scholar]
  • 14. ) Bogovski , P. and Bogovski , S.Animal species in which N‐nitroso compounds induce cancer . Int. J. Cancer , 27 , 471 – 474 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) IARC Monographs on the evaluation of carcinogenic risks of chemicals to humans . Supplement 7 . “ Overall Evaluations of Carcinogenicity: an Updating of IARC Monographs Volumes 1–42” ( 1987. ). International Agency for Research on Cancer; , Lyon . [PubMed] [Google Scholar]
  • 16. ) Hoch‐Ligeti , C. , Argus , M. F. and Arcos , J. C.Combined carcinogenic effects of dimethylnitrosamine and 3‐methyl‐cholanthrene in the rat . J. Natl. Cancer Inst. , 40 , 535 – 549 ( 1968. ). [PubMed] [Google Scholar]
  • 17. ) Argus , M. F. , Hoch‐Ligeti , C. , Arcos , J. C. and Conney , A. H.Differential effectsof β‐naphthoflavoneand pregnenolone‐I6α‐carbonitrileondimethylnltrosamine‐induced hepatocarcinogenesis . J. Natl. Cancer Inst. , 61 , 441 – 449 ( 1978. ). [PubMed] [Google Scholar]
  • 18. ) Nishizumi , M.Reduction of diethylnitrosamine‐induced hepatoma in rats exposed to polychlorinated biphenyls through their dams . Gann , 71 , 910 – 912 ( 1980. ). [PubMed] [Google Scholar]
  • 19. ) Swann , P. F. , Kaufman , D. G. , Magee , P. N. and Mace , R.Induction of kidney tumours by a single dose of dimethylnitrosamine, dose response and influence of diet and benzo[a]pyrene treatment . Br. J. Cancer , 41 , 285 – 294 ( 1980. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Kiessling , M. , Lipinski , R. , Böhm , N. and Kleihuess , P.Effect of pretreatment with pregnenolone‐16α‐carbonitrile and protein‐free diet on the metabolism and carcinogenicity of dimethylnitrosamine . Carcinogenesis , 2 , 757 – 761 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Schuller , H. M. and McMahon , J. B.Inhibition of N‐nitrosodiethylamine‐induced respiratory tract carcinogenesis by piperonyl butoxide in hamsters . Cancer Res. , 45 , 2807 – 2812 ( 1985. ). [PubMed] [Google Scholar]
  • 22. ) Habs , M. and Schmαhl , D.Inhibition of the hepatocarcinogenic activity of diethylnitrosamine (DENA) in rats . Hepatogastroenterology , 28 , 242 – 244 ( 1981. ). [PubMed] [Google Scholar]
  • 23. ) Appel , K. E. , Schwarz , M. , Rickert , R. and Kunz , W.Influence of inducers and inhibitors of the microsomal monooxygenasesystemonthealkylatingintensityof dimethylnitrosamine in mice . J. Cancer Res. Clin. Oncol. , 94 , 47 – 61 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Preston , B. D. , van Miller , J. P. , Moore , R. W. and Allen , J.R.Promoting effects of polychlorinated biphenyls (Aroclor 1254) andpolychlorinateddibenzofuran‐free Aroclor 1254 on diethylnitrosamine‐induced tumorigenesis in the rat . J. Natl. Cancer Inst. , 66 , 509 – 515 ( 1981. ). [PubMed] [Google Scholar]
  • 25. ) Schwartz , M. , Buchmann , A. , Klormann , H. , Schrenk , D. and Kunz , W.Effect of phenobarbital and other liver monooxygenase modifiers on dimethylnitrosamine‐induced alkylation of rat liver macromolecules . Cancer Res. , 45 , 2020 – 2024 ( 1985. ). [PubMed] [Google Scholar]
  • 26. ) Lai , D. Y. , Arcos , J. C. and Argus , M. F.Factors influencing the microsome‐ and mitochondria‐catalyzed in vitro binding of diethylnitrosamine and N‐nitrosopiperidine to deoxyribonucleic acid . Biochem. Pharmacol. , 28 , 3545 – 3550 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Bartsch , H. , Malaveille , C. and Montesano , R.Differentialeffectof phenobarbitone, pregnenolone‐16α‐carbonitrile and aminoacetonitrile on dialkylnitrosamine metabolism and mutagenicity in vitro . Chem.-Biol. Interact. , 10 , 377 – 382 ( 1975. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Hutton , J. J. , Hackney , C. and Meier , J.Mutagenicity and metabolism of dimethylnitrosamine and benzo[a]pyrene in tissue homogenates from inbred Syrian hamsters treated with phenobarbital, 3‐methylcholanthrene or polychlorinated biphenyls . Mutat. Res. , 64 , 363 – 377 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Button , J. J. , Meier , J. and Hackney , C.Comparison of the in vitro mutagenicity and metabolism of dimethylnitrosamine and benzo[a]pyrene in tissues from inbred mice treated with phenobarbital, 3‐methylcholanthrene of polychlorinated biphenyls . Mutat. Res. , 66 , 75 – 94 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Evarts , R. P. , Raab , M. M. , Haliday , E. and Brown , C.Pyrazole effects on mutagenicity and toxicity of dimethylnitrosamine in Wistar rats . Cancer Res. , 43 , 496 – 499 ( 1983. ). [PubMed] [Google Scholar]
  • 31. ) Mendoza‐Figueroa , T. , Lopez‐Revilla , R. and Villa‐Trevino , S.DNA breaks induced by micromolar concentrations of dimethylnitrosamine in liver primary cell cultures from untreated and phenobarbital treated rats . Toxicology , 27 , 55 – 69 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Yoo , J. S. and Yang , C. S.Enzyme specificity in the metabolic activation of N‐nitrosodimethylamine to a mutagen for Chinese hamster V79 cells . Cancer Res. , 45 , 5569 – 5574 ( 1985. ). [PubMed] [Google Scholar]
  • 33. ) Sato , A. , Yonekura , I. , Asakawa , M. , Nakahara , H. , Nakajima , T. , Ohta , S. , Shirai , T. and Ito , N.Augmentation of ethanol‐induced enhancement of dimethylnitrosamine and diethylnitrosamine metabolism by lowered carbohydrate intake . Jpn. J. Cancer Res. , 77 , 125 – 130 ( 1986. ). [PubMed] [Google Scholar]
  • 34. ) Malaveille , C. , Brun , G. , Park , S. S. , Gelboin , H. V. and Bartsch , H.A monoclonal antibody against cytochrome P‐450 enhances mutagen activation of N‐nitrosodimethylamine by mouse liver S9: studies on the mode of action . Carcinogenesis , 8 , 1775 – 1779 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Kolmodin , B. , Azarnoff , D. L. and Sjöqvist , F.Effect of environmentalfactors on drug metabolism:decreased plasma halflife ofantipyrine in workers exposed to chlorinated hydrocarbon insecticides . Clin. Pharmacol. Ther. , 94 , 947 – 954 ( 1969. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Alvares , A. , Fishbein , A. , Anderson , K. E. and Kappas , A.Alterations in drug metabolism in workers exposed to polychlorinatedbiphenyls . Clin. Pharmacol. Ther. , 22 , 140 – 146 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Danhof , M. , Krom , D. P. and Breimer , D. D.Studies on the different metabolic pathways of antipyrine in rats: influence ofphenobarbital and 3 ‐methylcholanthrene treatment . Xenobiotica , 9 , 695 – 702 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 38. ) Aitio , M‐L. , Mansury , L. , Tala , E. , Haataja , M. and Aitio , A.Effect of enzyme induction on the metabolism of disopyramide in man . Br. J. Clin. Pharmacol. , 11 , 279 – 286 ( 1981. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. ) Sotaniemi , E. A. , Pelkonen , R. O. , Ahokas , J. T. , Pirttiaho , H. and Ahlqvist , J.Relationship between in vivo andin vitro drug metabolism in man . Eur. J. Metab. Pharmacokinet. , 1 , 39 – 45 ( 1978. ). [Google Scholar]
  • 40. ) Roberfroid , M. B. , Malaveille , C. , Hautefeuille , A. , Brun , G. , Vo , T. O. and Bartsch , H.Interrelationships in mice of antipyrine half‐life, hepatic monooxygenase activities and liver S9‐mediated mutagenicity of aflatoxin Bl, benzo[a]‐pyrene 7,8‐dihydrodiol, 2‐acetyIaminofluoreneand N‐ nitrosomorpholine . Chem.-Biol. Interact. , 47 , 175 – 194 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 41. ) Higgins , G. M. and Anderson , R. M.Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal . Arch. Pathol , 12 , 186 – 202 ( 1931. ). [Google Scholar]
  • 42. ) Sabadie , N. , Malaveille , C. , Camus , A‐M. and Bartsch , H.Comparison of the hydroxylation of benzo[a]pyrene with the metabolism of vinyl chloride, N‐nitrosomorpholine and N‐nitroso‐N'‐methylpiperazine to mutagens by human and rat liver microsomal fractions . Cancer Res. , 40 , 119 – 126 ( 1980. ). [PubMed] [Google Scholar]
  • 43. ) Dehnen , W. , Tomingas , R. and Roos , J.A modified method for the assay of benzo[a]pyrene hydroxylase . Anal Biochem. , 53 , 373 – 383 ( 1973. ). [DOI] [PubMed] [Google Scholar]
  • 44. ) Aitio , A.A simple and sensitive assay of ethoxycoumarin deethylation . Anal. Biochem. , 85 , 488 – 491 ( 1978. ). [DOI] [PubMed] [Google Scholar]
  • 45. ) Nash , T.The colorimetric estimation of formaldehyde by means of the Hanzsch reaction . Biochem. J. , 55 , 416 – 421 ( 1953. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. ) Jerina , D. M. , Dansette , P. M. , Lu , A. Y. H. and Levin , M.Hepatic microsomal epoxide hydroxylase: a sensitive radiometric assay forhydration of areneoxides of carcinogenic aromatic hydrocarbons . Mol. Pharmacol , 13 , 342 – 351 ( 1977. ). [PubMed] [Google Scholar]
  • 47. ) James , M. O. , Pouts , J. R. and Bend , J. R.Hepatic and extrahepatic in vitro metabolism of an epoxide (8‐14Cstyrene oxide) in the rabbit . Biochem. Pharmacol , 25 , 187 – 193 ( 1976. ). [DOI] [PubMed] [Google Scholar]
  • 48. ) Aitio , A. and Bend , J. R.Inhibition of rat liver glutathione S‐transferase by aprotic solvents . FEBS Lett. , 101 , 187 – 190 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 49. ) Aitio , A.UDP glucuronosyltransferase activity in various rat tissues . Int. J. Biochem. , 85 , 488 – 491 ( 1974. ). [Google Scholar]
  • 50. ) Dawson , J. R. and Bridges , J. W.Guinea‐pig intestinal sulphotransferases: an investigation using the cytosol fraction . Biochem. Pharmacol. , 17 , 2409 – 2413 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 51. ) Lowry O. H. , Rosebrough , N. J. , Farr , A. L. and Randall , R. J.Protein measurement with the Folin phenol reagent . J. Biol. Chem. , 193 , 265 – 275 ( 1951. ). [PubMed] [Google Scholar]
  • 52. ) Gornall , A. G. , Bardawill , C. J. and David , M. M.Determination of serum proteins by means of the biuret reaction . J. Biol. Chem. , 177 , 751 – 766 ( 1949. ). [PubMed] [Google Scholar]
  • 53. ) Farmer , P. , Bailey , E. , Lamb , J. H. and Connors , T. A.Approach to the quantitation of alkylated amino acids in heamoglobin by gas chromatography mass spectrometry . Biomed. Mass Spectrom. , 7 , 41 – 46 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 54. ) van Doom , R. , Leijdekkers , C. M. , Bos , R. P. , Brouns , R. M. E. and Henderson , P. T.Detection of human exposure to electrophilic compounds by assay of thioether detoxication products in urine . Ann. Occup. Hyg. , 24 , 77 – 92 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 55. ) Pegg , A. E. , Perry , W. and Bennett , R. A.Effect of partial hepatectomy on removal of O6‐methylguanine from alkylated DNA by rat liver extracts . Biochem. J. , 197 , 195 – 201 ( 1981. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. ) Danhof , M. , Groot‐van der Vis , E. and Breimer , D. D.Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high‐performance liquid chromatography and some preliminary results in man . Pharmacology , 18 , 210 – 213 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 57. ) Lai , D. Y. and Arcos , J. C.Dialkylnitrosamine bioactivation and carcinogenesis . Life Sci. , 27 , 2149 – 2165 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 58. ) Janzowski , C. , Eisenbrand , G. , Gottfried , J. and Preussmann , R.Effects of fluorination on in vitro metabolism and biological activity on N‐nitrosodialkylamines . In “ N‐Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer ”, ed. O'Neill I.K. , von Borstel R. C. , Miller C. T. , Long J. and Bartsch H. , IARC Sci. Publ. No. 57 , pp. 553 – 558 ( 1984. ). IARC; , Lyon . [PubMed] [Google Scholar]
  • 59. ) Appel , K. E. , Ruehl , C. S. and Hildebrandt , A. G.Metabolic inactivation of N‐nitrosamines by cytochrome P‐450 in vitro and in vivo . In “ N ‐Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer ”, ed. O'Neill I. K. , von Borstel R. C. , Miller C. T. , Long J. and Bartsch H. , IARC Sci. Publ. No. 57 , pp. 443 – 451 ( 1984. ). IARC; , Lyon . [PubMed] [Google Scholar]
  • 60. ) Haussman , H. J. and Werringloer , J.Mechanism and control of denitrosation of N‐nitrosodimethylamine . In “ TheRelevanceof N‐Nitroso Compounds toHuman Cancer: Exposures and Mechanisms ”, ed. Bartsch H. , O'Neill I. K. and Schulte‐Hermann R. , IARC Sci. Publ. No. 84 , pp. 109 – 112 ( 1987. ). IARC; , Lyon . [PubMed] [Google Scholar]
  • 61. ) Keefer , L. K. , Anjo , T. , Heur , Y. H. , Yang , C. S. and Mico , B.A.Potential for metabolicdeactivation of carcinogenic N‐nitrosodimethylamine in vivo . In “ The Relevance of N‐nitroso Compounds to Human Cancer: Exposures and Mechanisms ”, ed. Bartsch H. , O'Neill I. K. and Schulte‐Hermann R. , IARC Sci. Publ. No. 84 , pp. 113 – 116 ( 1987. ). IARC; , Lyon . [PubMed] [Google Scholar]
  • 62. ) Ding , X. and Coon , M. J.Cytochrome P‐450‐dependent formation of ethylene from N‐nitrosodiethylamines . Drug Metab. Dispos. , 16 , 265 – 269 ( 1988. ). [PubMed] [Google Scholar]
  • 63. ) Magee , P. N. and Barnes , J. M.Carcinogenic nitroso compounds . Adv. Cancer Res. , 10 , 163 – 246 ( 1967. ). [DOI] [PubMed] [Google Scholar]
  • 64. ) Makiura , S. , Aoe , H. , Sugihara , S. , Hirao , K. , Aral , M. and Ito , N.Inhibitory effect of polychlorinated biphenyls on liver tumorigenesis in rats treated with 3′‐methyl‐4‐dimethylamino‐azobenzene, N‐2‐fluorenylacetamide, and diethylnitrosamine . J. Natl Cancer Inst. , 53 , 1253 – 1256 ( 1974. ). [DOI] [PubMed] [Google Scholar]
  • 65. ) Diaz Gomez , M. I. , Godoy , H. M. and Castro , J. A.Further studies on dimethylnitrosamine metabolism, activation and its ability to cause liver injury . Arch. Toxico. , 47 , 159 – 168 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 66. ) Yang , C. S. , Koop , D. R. , Wang , T. Y. and Coon , M. J.Immunochemical studies on the metabolism of nitrosarnines by ethanol‐inducible cytochrome P‐450 . Biochem. Biophys. Res. Commun. , 128 , 1007 – 1013 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 67. ) Levin , W. , Thomas , P. E. , Oldfield , N. and Ryan , D. E.N‐Demethylation of N‐nitrosodimethylamine catalyzed by purified rat hepatic microsomal cytochrome P‐ 450: isozyme specificity and role of cytochrome b5 . Arch. Biochem. Biophys. , 248 , 158 – 165 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 68. ) Wrighton , S. A. , Thomas , P. E. , Molowa , D. T. , Haniu , M. , Shively , J. E. , Maines , S. L. , Watkins , P. B. , Parker , G. , Mendez‐Picon , G. , Levin , W. and Guzelian , P. S.Characterization of ethanol‐inducible human liver JV‐nitro‐sodimethylaminedemethylase . Biochemistry , 25 , 6731 – 6735 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 69. ) Amelizad , S. , Appel , K. E. , Oesch , F. and Hildebrandt , A. G.Effect of antibodies against cytochrome P‐450 on demethylation and denitrosation of N‐nitrosodimethylamine and N‐nitrosomethylaniline . J. Cancer Res. Clin. Oncol. , 114 , 380 – 384 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 70. ) Hietanen , E. , Ahotupa , M. , Béréziat , J‐C , Park , S. S. , Gelboin , H. V. and Bartsch , H.Monoclonal antibody characterization of hepatic and extrahepatic cytochrome P‐450 activities in rats treated with phenobarbital or methylcholanthrene and fed various cholesterol diets . Biochem. Pharmacol. , 36 , 3973 – 3980 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 71. ) Ding , X. , Koop , B. , Crump , B. L. and Coon , M. J.Immunochemical identification ofcytochrome P‐ 450 isozyme 3a (P‐450ALC) in rabbit nasal and kidney microsomes and evidence for differential induction by alcohol . Mol Pharmacol. , 30 , 370 – 378 ( 1986. ). [PubMed] [Google Scholar]
  • 72. ) Thomas , P. E. , Bandiera , S. , Maines , S. L. , Ryan , D. E. and Levin , W.Regulation of cytochrome P4501, a high affinity N‐nitrosodimethylamine demethylase, in rat hepatic microsomes . Biochemistry , 26 , 2280 – 2289 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 73. ) Longo , V. , Citti , L. and Gervasi , P. G.Metabolism of diethylnitrosamine by nasal mucosa and hepatic microsomes from hamster and rat. Species specificity of nasal raucosa . Carcinogenesis , 1 , 1323 – 1328 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 74. ) Prasanna , H. R. , Raj , H. G. , Lotlikar , P. D. and Magee , P. N.Lack of effect of glutathione on the binding of dimethylnitrosamine to DNA in vitro . Mol. Toxicol. , 1 , 167 – 176 ( 1987. ). [PubMed] [Google Scholar]
  • 75. ) Inaba , T. , Lucassen , M. and Kalow , W.Antipyrine metabolism in the rat by three hepatic monooxygenases . Life Sci. , 26 , 1977 – 1983 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 76. ) Kahn , G. M. , Boobis , A. R. , Murray , S. and Davies , D. S.Differential effects of 3‐methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver . Xenobiotica , 12 , 509 – 516 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 77. ) Teunissen , M. W. E. , Meerburg‐van der Torren , J. E. , Vermeulen , N. P. E. and Breimer , D. D.Automated high‐performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4′‐dihydroxyantipyrine . J. Chromatogr. , 278 , 367 – 378 ( 1983. ). [PubMed] [Google Scholar]
  • 78. ) Kato , R. and Takanaka , A.Metabolism of drugs in old rats (I). Activities of NADPH‐Iinked electron transport and drug‐metabolizing enzyme systems in liver microsomes of old rats . Jpn. J. Pharmacol. , 18 , 381 – 388 ( 1968. ). [DOI] [PubMed] [Google Scholar]
  • 79. ) Kato , R. and Takanaka , A.Metabolism of drugs in old rats (II). Metabolism in vivo and effects of drugs in old rats . Jpn. J. Pharmacol. , 18 , 389 – 396 ( 1968. ). [DOI] [PubMed] [Google Scholar]
  • 80. ) Schmucker , D. L. and Wang , R. K.Age‐related changes in liver drug‐metabolizing enzymes . Exp. Gerontol. , 15 , 321 – 329 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 81. ) Bertram , B. , Frei , E. , Scherf , H. R. , Schumacher , J. , Tacchi , A. M. and Wiessler , M.Influence of prolonged treatment with disulfiram and D‐(‐)‐penicillamine on nitrosodiethylamine‐induced biological and biochemical effects in rats . J. Cancer Res. Clin. Oncol. , 109 , 9 – 15 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 82. ) Lai , D. Y. , Bryant , G. M , Myers , S. C. , Woo , Y‐T. , Argus , M. and Arcos , J. C.Evolution of activation‐detoxification enzyme patterns during precarcinogenesis in synergism; 3‐methylcholanthrene and dimethylnitrosamine . J. Cancer Res. Clin. Oncol. , 103 , 227 – 240 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 83. ) Garcea , R. , Canute , R. A. , Biocca , M. E. , Muzio , G. , Rossi , M. A. and Dianzani , M. U.Functional alterations of the endoplasmic reticulum and the detoxification systems during diethylnitrosamine carcinogenesis in rat liver . Cell Biochem. Fund. , 2 , 177 – 180 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 84. ) Umbenhauer , D. , Wild , C. P. , Montesano , R. , Saffhill , R. , Boyle , J. M. , Huh , N. , Kirstein , U. , Thomale , J. , Rajewsky , M. F. and Lu , S. H.O6‐Methyldeoxyguanosine in oesophageal DNA among individuals at high risk for oesophageal cancer . Int. J. Cancer , 36 , 661 – 665 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 85. ) Bartsch , H. , Ohshima , H. , Pignatelli , B. and Calmels , S.Human exposure to endogenous N‐nitroso compounds: quantitative estimates in subjects at high risk for cancer of the oral cavity, oesophagus and urinary bladder . Cancer Surv. , 8 , 335 – 362 ( 1989. ). [PubMed] [Google Scholar]
  • 86. ) Hecht , S. S. and Hoffmann , D.The relevance of tobacco‐specific nitrosamines to human cancer . Cancer Surv. , 8 , 273 – 294 ( 1989. ). [PubMed] [Google Scholar]
  • 87. ) Bartsch , H. , Hietanen , E. , Petruzzelli , S. , Giuntini , C. , Saracci , R. , Mussi , A. and Angeletti , C. A.Possible prognostic value of pulmonary Ah‐locus‐linked enzymes in patients with tobacco‐related lung cancer . Int. J. Cancer , 46 , 185 – 188 ( 1990. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES